MENU
NEWSLETTERS
MENU
SECTIONS
OTHER
CLASSIFIEDS
CONTACT US / FAQ
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Glaukos Corporation Common Stock (NY:GKOS)

117.47 UNCHANGED
Streaming Delayed Price Updated: 7:00 PM EST, Feb 2, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1
Open 117.47
Bid (Size) 95.05 (300)
Ask (Size) 139.60 (100)
Prev. Close 117.47
Today's Range 117.47 - 117.47
52wk Range 73.16 - 161.78
Shares Outstanding 55,137,429
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Director Sells GKOS 15,000 Shares for $1.9 Million ↗
This ophthalmic device maker, focused on glaucoma solutions, reported a notable insider sale after a challenging year for its stock. 
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Glaukos Announces US FDA Approval of NDA Supplement Allowing for Re-Administration of iDose® TR
From Glaukos Corporation
Via Business Wire

Performance

YTD
+6.1%
+6.1%
1 Month
+4.4%
+4.4%
3 Month
+34.4%
+34.4%
6 Month
+34.3%
+34.3%
1 Year
-24.7%
-24.7%

More News

Read More
News headline image
Glaukos to Release Fourth Quarter and Full Year 2025 Financial Results after Market Close on February 17
From Glaukos Corporation
Via Business Wire
News headline image
Earnings Scheduled For October 29, 2025 ↗
Via Benzinga
These stocks are moving in today's after hours session ↗
Via Chartmill
News headline image
Glaukos Announces Preliminary, Unaudited Fourth Quarter and Full Year 2025 Net Sales and Reaffirms 2026 Revenue Guidance
From Glaukos Corporation
Via Business Wire
News headline image
Glaukos Announces Participation in J.P. Morgan Healthcare Conference
From Glaukos Corporation
Via Business Wire
News headline image
Brown Capital Sells $35 Million in Glaukos Stock After Sharp Sell-Off ↗
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Glaukos Announces Participation in Upcoming Investor Conferences
From Glaukos Corporation
Via Business Wire
News headline image
Why Glaukos Stock Zoomed Almost 14% Higher on Thursday ↗
Via The Motley Fool
News headline image
Glaukos (GKOS) Q3 2025 Earnings Call Transcript ↗
Via The Motley Fool
Topics Earnings
News headline image
Cardinal Health Posts Upbeat Q1 Results, Joins Guardant Health, Glaukos, C.H. Robinson And Other Big Stocks Moving Higher On Thursday ↗
Via Benzinga
News headline image
Get insights into the top gainers and losers of Thursday's pre-market session. ↗
Via Chartmill
News headline image
12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗
Via Benzinga
News headline image
Alphabet To Rally Around 22%? Here Are 10 Top Analyst Forecasts For Thursday ↗
Via Benzinga
News headline image
Why Alphabet Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket ↗
Via Benzinga
News headline image
Why Glaukos Stock Jumped Over 20% After-Hours Today ↗
Via Stocktwits
News headline image
What's going on in today's after hours session ↗
Via Chartmill
News headline image
Glaukos Corp (NYSE:GKOS) Soars on Strong Q3 2025 Earnings Beat and Robust 2026 Outlook ↗
Via Chartmill
Topics Earnings
News headline image
12 Health Care Stocks Moving In Wednesday's After-Market Session ↗
Via Benzinga
News headline image
Glaukos Announces Third Quarter 2025 Financial Results
From Glaukos Corporation
Via Business Wire
News headline image
Booking Holdings To Rally Around 12%? Here Are 10 Top Analyst Forecasts For Monday ↗
Via Benzinga
News headline image
This Five Below Analyst Turns Bullish; Here Are Top 5 Upgrades For Monday ↗
Via Benzinga
News headline image
Glaukos Announces FDA Approval of Epioxa™
From Glaukos Corporation
Via Business Wire
News headline image
Glaukos Innovation to be Highlighted at the 2025 American Academy of Ophthalmology Annual Meeting
From Glaukos Corporation
Via Business Wire

Frequently Asked Questions

Is Glaukos Corporation Common Stock publicly traded?
Yes, Glaukos Corporation Common Stock is publicly traded.
What exchange does Glaukos Corporation Common Stock trade on?
Glaukos Corporation Common Stock trades on the New York Stock Exchange
What is the ticker symbol for Glaukos Corporation Common Stock?
The ticker symbol for Glaukos Corporation Common Stock is GKOS on the New York Stock Exchange
What is the current price of Glaukos Corporation Common Stock?
The current price of Glaukos Corporation Common Stock is 117.47
When was Glaukos Corporation Common Stock last traded?
The last trade of Glaukos Corporation Common Stock was at 02/02/26 07:00 PM ET
What is the market capitalization of Glaukos Corporation Common Stock?
The market capitalization of Glaukos Corporation Common Stock is 6.48B
How many shares of Glaukos Corporation Common Stock are outstanding?
Glaukos Corporation Common Stock has 6B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story